Startups
LEUKOCARE is a leading provider of technologies for biological functionalization of medical devices, as well as the stabilization and protection of proteins and biological molecules in biopharmaceutical formulations in order to ensure safety, to extend shelf-life and to enable terminal sterilization.
As a product-focused biotechnology company, LEUKOCARE uses its proprietary Stabilizing and Protecting Solutions (SPS) to leverage its comprehensive expertise in industrial co-development partnerships. The company offers its know-how in formulation of biologics, biofunctional coatings of combination devices and product development.
LEUKOCARE was founded in 2003 and is headquartered in Martinsried near Munich, Germany.
As a product-focused biotechnology company, LEUKOCARE uses its proprietary Stabilizing and Protecting Solutions (SPS) to leverage its comprehensive expertise in industrial co-development partnerships. The company offers its know-how in formulation of biologics, biofunctional coatings of combination devices and product development.
LEUKOCARE was founded in 2003 and is headquartered in Martinsried near Munich, Germany.
Overview
Location
Germany, Bavaria, Martinsried
Employees
51-200
Total raised
$17.5M
Founded date
2003
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 23, 2021 | PRESS RELEASE : Leukocare Announces USD 17.5 million Financing Round to Further Expand US Business and Bioinformatics Activities | DGAP-News: LEUKOCARE AG / Key word(s): Financing Leukocare Announces USD 17.5 million Financing Round to Further Expand US Business and Bioinformatics Activities 2021-06-23 / 09:30 The issuer is solely responsible for the content of this an... |
| Jun 23, 2021 | Leukocare : Announces USD 17.5 million Financing Round to Further Expand US Business and Bioinformatics Activities | DGAP-News: LEUKOCARE AG / Key word(s): Financing Leukocare Announces USD 17.5 million Financing Round to Further Expand US Business and Bioinformatics Activities 23.06.2021 / 09:30 The issuer is solely responsible for the content of this an... |
| Jun 23, 2021 | Leukocare Raises USD 17.5M in Financing | Leukocare AG, a Martinsried/Munich, Germany and Milford, MA, USA-based biotechnology company specialized in the field of biopharmaceutical formulation development, closed a USD 17.5m (€14.6m) financing. The round was led by Petrichor Health... |
| Apr 1, 2020 | Coronavirus Business Tracker: How The Private Sector Is Fighting The Covid-19 Pandemic | Alain Mérieux, founder of BioMérieux.AFP via Getty Images |
| Jul 22, 2015 | Leukocare Closes Growth Financing | Leukocare, a Munich, Germany-based clinical-stage biotechnology company, closed a growth financing round of undisclosed amount. The round was led by LifeCare Partners, with participation from a group of new investors and current shareholder... |
Reviews 0
FAQ about Leukocare AG
When was Leukocare AG founded?
Leukocare AG was founded in 2003.
How much funding has Leukocare AG raised?
Leukocare AG has raised $17.5M in total across 1 funding round.
What has the press written about Leukocare AG?
Parsers VC has collected 6 articles mentioning Leukocare AG, among them “PRESS RELEASE : Leukocare Announces USD 17.5 million Financing Round to Further Expand US Business and Bioinformatics Activities” (Jun 23, 2021) and “Leukocare : Announces USD 17.5 million Financing Round to Further Expand US Business and Bioinformatics Activities” (Jun 23, 2021).
Is Leukocare AG still active?
Yes, Leukocare AG is active; its latest activity on Parsers VC dates from Jun 23, 2021.